2 Followers SGX:BFK - Pharmesis Intl Pharmesis Intl
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance See related symbol P31


SGD 0.265    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

3 Dec 2020


Overview

52 Wk Range: 0.117 - 0.625

Day's Range: 0.265 - 0.265

Last Volume: 0

Current Yield: 0%

Projected Yield: 0%

SMA-50: SGD 0.27

SMA-200: SGD 0.25

Beta: -0.2

VaR: 77.32%

Liquidity: 0

Fundamental

P/E: NA

Market Cap: SGD 6.09M

P/B: 0.51

ROE: -24.7%

Insider Holdings (%): 72.51%

General

CEO: Mr. Jie Qi

Headquarters: SG

Employees: 0

Homepage

Description

Pharmesis International Ltd is a Singapore based pharmaceutical company. It manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. The company produces Western medicine and TCM formulated products. Western medicine refers to chemically formulated drugs and is marketed under the Kinna brand. TCM formulated drugs refers to Traditional Chinese Medicine and are marketed under the Longlife brand. Its Western medicine range consists mainly of Anetholtrithione tablets, and TCM formulated products consist mainly of Gansu granules. The group generates the majority of the revenue from the sales of TCM formulated drugs. The company sells its products principally in the People's Republic of China.